Radiolabeling, Quality Control, and Cell Binding Studies of New < sup > 99m < /sup > Tc-Labeled Bisphosphonates: < sup > 99m < /sup > Tc-Ibandronate Sodium

CONCLUSION: The newly produced radiopharmaceutical is very promising according to the results of in vitro cell culture, HA binding, and quality studies, and will be a step forward for further studies in nuclear medicine for bone cancer diagnostics.PMID:37161446 | DOI:10.4274/tjps.galenos.2022.01346
Source: Cancer Control - Category: Cancer & Oncology Authors: Source Type: research